Two Sigma Advisers’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,470
| Closed | -$219K | – | 2471 |
|
|
2017
Q3 | $219K | Sell |
7,470
-700
| -9% | -$19.6K | ﹤0.01% | 2031 |
|
|
2017
Q2 | $214K | Sell |
8,170
-10,000
| -55% | -$246K | ﹤0.01% | 2101 |
|
|
2017
Q1 | $425K | Buy |
+18,170
| New | +$448K | ﹤0.01% | 1961 |
|
|
2016
Q3 | – | Sell |
-59,570
| Closed | -$1.47M | – | 2380 |
|
|
2016
Q2 | $1.47M | Sell |
59,570
-4,800
| -7% | -$119K | 0.01% | 991 |
|
|
2016
Q1 | $1.42M | Sell |
64,370
-11,700
| -15% | -$311K | 0.01% | 959 |
|
|
2015
Q4 | $2.66M | Buy |
76,070
+200
| +0.3% | +$6.26K | 0.02% | 655 |
|
|
2015
Q3 | $2.17M | Sell |
75,870
-15,600
| -17% | -$524K | 0.01% | 712 |
|
|
2015
Q2 | $3.05M | Buy |
91,470
+35,900
| +65% | +$1.1M | 0.02% | 645 |
|
|
2015
Q1 | $1.57M | Buy |
55,570
+38,300
| +222% | +$952K | 0.01% | 879 |
|
|
2014
Q4 | $358K | Sell |
17,270
-44,000
| -72% | -$1.04M | ﹤0.01% | 1838 |
|
|
2014
Q3 | $1.5M | Sell |
61,270
-19,900
| -25% | -$528K | 0.01% | 922 |
|
|
2014
Q2 | $2.32M | Buy |
81,170
+18,100
| +29% | +$503K | 0.02% | 754 |
|
|
2014
Q1 | $1.76M | Buy |
63,070
+14,100
| +29% | +$346K | 0.02% | 834 |
|
|
2013
Q4 | $1.05M | Buy |
+48,970
| New | +$890K | 0.01% | 1105 |
|
|
2013
Q3 | – | Sell |
-33,670
| Closed | -$467K | – | 2527 |
|
|
2013
Q2 | $467K | Buy |
+33,670
| New | +$477K | 0.01% | 1369 |
|
Two Sigma Advisers's PMC Position: Q4 2017 in Review
Two Sigma Advisers sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 7,470 shares — an estimated $219K sold.
Two Sigma Advisers first reported a position in PMC in Q2 2013 and held it in 15 quarters. The position peaked at $3.05M in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Two Sigma Advisers reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Two Sigma Advisers sold 7,470 PharMerica Corporation shares in Q4 2017, an estimated $219K.
- Two Sigma Advisers first reported a position in PharMerica Corporation in Q2 2013 and held it in 15 quarters.
- Two Sigma Advisers's PharMerica Corporation position peaked at $3.05M in Q2 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.